There are over 6 million regional anaesthetic blocks performed per year throughout the EU and US. SAFIRA could unlock regional anaesthesia in developing markets, making a total available market of 10 million procedures. Investment funding of £250,000 is sought to match other funding applications and develop the technology through to FIM. SAFIRA will be an attractive acquisition proposition for BBraun, Pajunk, Vygon, Teleflex, GE or Philips.